BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9219824)

  • 1. Prevalence of mutations and 30-bp deletion in the C-terminal region of Epstein-Barr virus latent membrane protein-1 oncogene in reactive lymphoid tissue and non-nasopharyngeal EBV-associated carcinomas in Hong Kong Chinese.
    Leung SY; Yuen ST; Chung LP; Chan AS; Wong MP
    Int J Cancer; 1997 Jul; 72(2):225-30. PubMed ID: 9219824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong.
    Cheung ST; Leung SF; Lo KW; Chiu KW; Tam JS; Fok TF; Johnson PJ; Lee JC; Huang DP
    Int J Cancer; 1998 May; 76(3):399-406. PubMed ID: 9579578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of Epstein-Barr virus latent membrane protein 1 gene in United States and Brazilian Hodgkin's disease and reactive lymphoid tissue: high frequency of a 30-bp deletion.
    Hayashi K; Chen WG; Chen YY; Bacchi MM; Bacchi CE; Alvarenga M; Abreu ES; Chang KL; Weiss LM
    Hum Pathol; 1997 Dec; 28(12):1408-14. PubMed ID: 9416698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.
    Hayashi K; Chen WG; Chen YY; Murakami I; Chen HL; Ohara N; Nose S; Hamaya K; Matsui S; Bacchi MM; Bacchi CE; Chang KL; Weiss LM
    Am J Pathol; 1998 Jan; 152(1):191-8. PubMed ID: 9422536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Various 30 and 69 bp deletion variants of the Epstein-Barr virus LMP1 may arise by homologous recombination in nasopharyngeal carcinoma of Tunisian patients.
    Hadhri-Guiga B; Khabir AM; Mokdad-Gargouri R; Ghorbel AM; Drira M; Daoud J; Frikha M; Jlidi R; Gargouri A
    Virus Res; 2006 Jan; 115(1):24-30. PubMed ID: 16154221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia.
    See HS; Yap YY; Yip WK; Seow HF
    World J Surg Oncol; 2008 Feb; 6():18. PubMed ID: 18275617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders.
    Smir BN; Hauke RJ; Bierman PJ; Gross TG; d'Amore F; Anderson JR; Greiner TC
    Lab Invest; 1996 Oct; 75(4):575-88. PubMed ID: 8874388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [C-terminal 30 bp-deletion mutation of latent membrane protein 1 gene of Epstein-barr virus in non-hodgkin's lymphoma].
    Liu JR; Lin Q; Wu XY
    Ai Zheng; 2005 Feb; 24(2):145-8. PubMed ID: 15694022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein--Barr virus gene polymorphisms in Chinese Hodgkin's disease cases and healthy donors: identification of three distinct virus variants.
    Zhou XG; Sandvej K; Li PJ; Ji XL; Yan QH; Zhang XP; Da JP; Hamilton-Dutoit SJ
    J Gen Virol; 2001 May; 82(Pt 5):1157-1167. PubMed ID: 11297690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue.
    Dirnhofer S; Angeles-Angeles A; Ortiz-Hidalgo C; Reyes E; Gredler E; Krugmann J; Fend F; Quintanilla-Martinez L
    Hum Pathol; 1999 Jul; 30(7):781-7. PubMed ID: 10414496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the Epstein-Barr virus infection and 30 bp-deleted LMP1 gene among 4 histologic types of nasopharyngeal carcinoma].
    Zhang M; Zong YS; He JH; Zhong BL; Lin SX; Liang YJ
    Zhonghua Bing Li Xue Za Zhi; 2003 Aug; 32(4):342-6. PubMed ID: 14514380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational events in LMP1 gene of Epstein-Barr virus in salivary gland lymphoepithelial carcinomas.
    Jen KY; Cheng J; Li J; Wu L; Li Y; Yu S; Lin H; Chen Z; Gurtsevitch V; Saku T
    Int J Cancer; 2003 Jul; 105(5):654-60. PubMed ID: 12740914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of Epstein-Barr virus gene polymorphisms in nasal T/NK-cell lymphomas and normal nasal tissues: implications on virus strain selection in malignancy.
    Chiang AK; Wong KY; Liang AC; Srivastava G
    Int J Cancer; 1999 Jan; 80(3):356-64. PubMed ID: 9935174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas.
    Jen KY; Higuchi M; Cheng J; Li J; Wu LY; Li YF; Lin HL; Chen Z; Gurtsevitch V; Fujii M; Saku T
    Virus Genes; 2005 Mar; 30(2):223-35. PubMed ID: 15744579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders.
    Scheinfeld AG; Nador RG; Cesarman E; Chadburn A; Knowles DM
    Am J Pathol; 1997 Sep; 151(3):805-12. PubMed ID: 9284829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of monoclonal antibodies against Hong Kong nasopharyngeal carcinoma-associated Epstein-Barr virus latent membrane protein 1 (LMP1).
    Chan BC; To KF; Pang JC; Chung YF; Lo KW; Tong JH; Huang DW; Lim PL; Chui YL
    Int J Cancer; 2002 Dec; 102(5):492-8. PubMed ID: 12432552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethnic differences in the expression of Epstein-Barr virus latent membrane protein-1 mutations in nasopharyngeal carcinoma.
    D'Addario M; Chauvin P
    Mutat Res; 2000 Dec; 457(1-2):69-78. PubMed ID: 11106799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epstein-Barr Virus LMP1 oncogene variants in cell lines of different origin].
    Yakovleva LS; Senyuta NB; Goncharova EV; Scherback LN; Smirnova RV; Pavlish OA; Gurtsevitch VE
    Mol Biol (Mosk); 2015; 49(5):800-10. PubMed ID: 26510598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxy-terminal sequence variation of LMP1 gene in Epstein-Barr-virus-associated mononucleosis and tumors from Serbian patients.
    Banko A; Lazarevic I; Cupic M; Stevanovic G; Boricic I; Jovanovic T
    J Med Virol; 2012 Apr; 84(4):632-42. PubMed ID: 22337303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.